More than calories: Can an iron-rich potato change a family’s health?

Peru is moving two biofortified potato varieties into its seed system—but delivering better nutrition will require far more than successful breeding

By Lukie Pieterse, Editor/Publisher of Potato News Today

A potato breeder can increase the concentration of iron in a tuber. That is difficult enough. The much harder task is ensuring that the potato reaches a farmer, performs in the field, survives multiplication, appeals to the person cooking it and is eaten frequently enough to make a measurable difference to health.

Peru is now attempting that transition.

Two conventionally bred, iron-rich potato varieties—CIP-Kallpa Yawri and CIP-Puka Yawri—are moving from research into the country’s certified seed system. The International Potato Center, known as CIP, and Peru’s National Institute of Agricultural Innovation, INIA, are multiplying planting material while establishing demonstration fields and introducing the varieties to farmers, universities and public institutions.

During 2025, CIP delivered 50,000 in vitro plants of the two varieties to INIA. The plants are expected to form the foundation for approximately 1,500 tonnes of certified seed, enough to plant about 1,000 hectares and potentially reach more than 32,000 farming families.

Those are projected outcomes, not yet completed ones. The distinction matters.

The plantlets represent the start of a multiplication chain. Whether the projected seed volume is achieved—and whether farmers continue growing the varieties after the first distribution—will be a more demanding test than producing healthy material under controlled conditions.

Nevertheless, the initiative has reached an important threshold. Biofortification is leaving the breeding programme and entering the less predictable world of farms, households and markets.

A public-health problem rooted in everyday life

Anaemia remains one of the world’s most persistent health problems. The World Health Organization estimates that it affects approximately 40% of children aged six to 59 months, 37% of pregnant women and 30% of women between 15 and 49 years of age.

Iron deficiency is a major cause, although it is far from the only one. Anaemia can also result from infections, chronic disease, blood loss, inherited disorders and deficiencies involving other nutrients.

This means an iron-rich potato cannot be presented honestly as a cure for anaemia.

What it may offer is a practical additional source of dietary iron in places where potatoes are already grown and eaten regularly. Instead of asking families to adopt an unfamiliar food or depend entirely on a purchased supplement, biofortification attempts to improve the nutritional contribution of an established staple.

That is especially relevant in the Peruvian highlands, where potatoes remain closely woven into farming, food culture and household survival. For many families, the crop is not an occasional side dish. It is a substantial part of the daily diet.

The opportunity lies in that familiarity. The limitation lies there too: a nutritionally improved variety must still taste, cook, store and sell like a potato people want.

Twenty years of breeding behind two varieties

CIP’s work on iron-rich potatoes began more than two decades ago with the screening of native and improved material for micronutrient concentration.

Hundreds of potato varieties were assessed. Breeders then combined promising nutritional characteristics with traits that matter in the field and kitchen, including yield, adaptation to high elevations, culinary quality and resistance to late blight.

More than 13,000 breeding candidates were reportedly created before the field was narrowed to the most promising material. Between 2018 and 2021, candidates were tested across 26 locations in Peru’s highlands.

Farmers were not brought in only at the end. More than 1,600 participated in selection at different crop stages, helping evaluate agronomic performance and characteristics that influence adoption.

The resulting varieties, CIP-Kallpa Yawri and CIP-Puka Yawri, were registered in Peru in 2025. They are intended for production between approximately 2,600 and 4,200 metres above sea level and, under suitable conditions, can produce more than 20 tonnes per hectare.

That compares favourably with the roughly eight tonnes per hectare that CGIAR reports as typical for many traditional highland production systems. Such comparisons must be interpreted carefully, because yield depends heavily on location, seed health, weather and crop management.

Nevertheless, the breeding programme understood a central truth: nutritional quality cannot rescue an agronomically weak variety. Farmers cannot be expected to sacrifice their livelihoods for a theoretical public-health benefit.

What the human trial actually showed

The strongest scientific argument for iron-biofortified potatoes comes from controlled absorption research involving women in the Peruvian highlands.

In a randomised crossover trial published in The Journal of Nutrition in 2023, 28 women consumed ten meals made from an iron-biofortified yellow-fleshed breeding clone and ten meals made from the commercial variety Peruanita.

Each meal contained 460 grams of potato. Researchers used stable iron isotopes to determine how much iron entered the participants’ blood.

The biofortified potato delivered approximately 0.35 milligrams of absorbed iron per meal, compared with 0.24 milligrams from the conventional potato. Total absorbed iron was therefore 45.8% higher from the biofortified meals.

There is an important nuance. The percentage of available iron absorbed by the body was lower for the biofortified potato. However, because the tubers contained considerably more iron, the total amount absorbed was greater.

That is an encouraging finding, but it should not be stretched beyond what the trial measured.

The study demonstrated improved iron delivery from controlled meals. It did not establish that distributing these potatoes across Peru will reduce anaemia by a particular percentage. That would require longer-term research examining consumption, iron status, health outcomes and the many other causes of anaemia.

The distinction between more absorbed iron and less population-level anaemia may sound cautious. It is scientifically essential.

The potato has an unusual nutritional advantage

Plant-based iron is often difficult for the body to absorb. Compounds in some foods can bind to it, while vitamin C can improve its availability.

Potatoes present an interesting combination. They contain vitamin C and generally have lower levels of phytate than several cereal and legume staples. Human studies in Peru have consequently found relatively high iron absorption from potatoes, although variety, flesh colour, preparation and the rest of the meal can influence the result.

Consumption volume also matters.

A potato may not appear exceptionally rich in iron when compared gram for gram with certain other foods. But in regions where people consume several hundred grams at a meal, the crop can become an important contributor to total intake.

This is why the approach is context-specific. An iron-rich potato could have meaningful value in high-consumption areas of the Andes. It may offer less nutritional impact in a country where potatoes are eaten infrequently or mainly as highly processed products.

Biofortification must begin with what people actually eat—not with what researchers hope they will eat.

The seed-system test begins now

The delivery of 50,000 in vitro plants attracted attention because it made decades of research visible. Yet those delicate plantlets are several production stages removed from a farmer’s field.

They must be multiplied while remaining healthy and true to variety. Certified seed production must expand without allowing viruses, bacterial wilt or other pathogens to undermine the material. Seed must then be stored, transported and sold or distributed at the correct time.

The projected 1,500 tonnes will not appear automatically.

Nor will a first distribution guarantee long-term availability. Seed programmes sometimes succeed in placing a new variety with farmers but fail to create enough commercial demand for continued multiplication.

A sustainable system will require growers willing to produce seed, inspectors able to maintain quality, organisations capable of aggregating demand and farmers who believe the additional value justifies the price.

If public programmes purchase the first seed but ordinary farmers do not return for the next generation, the varieties may remain dependent on projects and promotional campaigns.

That would represent distribution, but not adoption.

Farmers and consumers will make the final selection

Participatory breeding improves the likelihood that a variety meets local expectations, but preferences can change as production expands.

Farmers will judge yield stability, maturity, disease response, seed requirements and performance during difficult seasons. Traders will judge appearance, uniformity and handling. Household cooks will judge texture, flavour, cooking time and suitability for familiar dishes.

These decisions are connected.

A variety may have excellent nutritional quality but lose value if its skin colour is unfamiliar in the local market. It may yield well but sprout too quickly in storage. It may perform on research plots yet demand inputs that smallholders cannot reliably obtain.

Price will also matter. Consumers facing limited household budgets may support the idea of improved nutrition while continuing to buy the least expensive available potato.

Nutrition messaging therefore needs care. Families should receive clear information, but a new variety should not be marketed in a way that exaggerates medical benefits or implies that consumers are responsible for solving a structural public-health problem through shopping choices alone.

Women carry the burden—but should not carry the entire solution

Anaemia disproportionately affects women and young children, which makes them central to the purpose of the programme.

It does not mean that responsibility for adoption should be placed entirely on women.

Women may select seed, manage plots, prepare meals and care for children while having limited control over land, income or crop sales. A household may sell the biofortified crop and consume a cheaper variety. Men may make marketing decisions while women are expected to deliver the nutritional benefit.

These social realities can determine whether the intervention works.

Evaluation should therefore examine who controls the seed, who performs the additional labour, who decides what is sold and who ultimately eats the potatoes. Reaching a farming family is not the same as reaching every person within it.

The most successful programmes will involve men and women, producers and consumers, agricultural extension personnel and health workers. Nutrition cannot remain an agricultural message delivered only at planting time.

Part of the answer—not the whole answer

Biofortified potatoes should complement rather than compete with dietary diversity, supplementation, conventional food fortification, infection control and appropriate medical care.

That may appear to weaken the claim being made for the crop. In reality, it makes the case more credible.

No single food can address every cause of anaemia. But a staple that delivers additional absorbable iron without requiring a major change in eating habits could become a useful part of a broader strategy.

The advantages are particularly relevant in rural communities that have limited access to industrially fortified foods or where supplement programmes are inconsistent. Once a suitable variety is established, its nutritional characteristic is reproduced each time healthy seed is multiplied.

The danger is assuming that the trait alone guarantees impact. Nutritional value is created by breeding but delivered through seed systems, farming, markets, cooking and consumption.

Every weak link reduces the benefit.

A lesson with global relevance

CIP and its partners are also investigating biofortified potatoes for parts of Africa and Asia. The opportunity is real in countries where potato consumption is rising and iron deficiency remains widespread.

But Peru’s varieties cannot simply be exported as a universal answer.

Local breeding and testing will still be required. A variety adapted to the Peruvian Andes may not tolerate East African disease pressure, South Asian heat or the storage conditions faced by growers elsewhere. Consumer preferences also differ sharply among regions.

The transferable lesson is therefore not one particular cultivar. It is the method: identify a nutritional need, work with existing diets, breed for agronomic and consumer traits simultaneously, test actual absorption and build the seed system before claiming success.

What should be measured next

The next phase should be judged through more than tonnes of seed produced or hectares planted.

Researchers and public agencies will need to track whether farmers plant the varieties again, whether seed remains affordable, whether women and children consume the crop, and whether the potatoes retain their market and culinary value.

Ultimately, well-designed longer-term studies must determine whether regular consumption improves iron status and contributes to lower anaemia rates under ordinary household conditions.

Some of the results may be disappointing. Adoption may vary between communities. A variety may need further agronomic improvement. Promotional distribution may produce less sustained demand than expected.

Those findings should be published too.

Peru’s iron-rich potatoes represent a serious and imaginative attempt to connect crop breeding with human wellbeing. The work deserves attention precisely because it has progressed beyond a promising breeding line.

But the most important achievement will not be a potato containing more iron.

It will be a potato that farmers choose to grow, families can afford, people enjoy eating—and that careful evidence eventually shows has improved someone’s life.